about
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature ReviewNon invasive tools for the diagnosis of liver cirrhosis.Nanotechnology applications for the therapy of liver fibrosis.Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.Sex hormones and risk of liver tumor.Late-onset Sheehan's syndrome presenting with rhabdomyolysis and hyponatremia: a case report.Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinomaClinical course and management of acute and chronic viral hepatitis during pregnancy.Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case reportVariation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance.Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C.Hepatocellular carcinoma: comparison of two different periods at the same center.Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment.Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine.Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer.Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy].IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral AgentsSubclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective studyEffects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic SyndromeA Key Role for Abdominal Ultrasound Examination in ”Difficult” Diagnoses of Celiac DiseaseAssociation Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-α, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular CarcinomaFrequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular CarcinomaCirculating Levels of Adhesion Molecules in Chronic Kidney Disease Correlate with the Stage of Renal Disease and with C-Reactive ProteinSignificance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular CarcinomaLeucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-InterferonsExtreme thrombocytosis as a sign of coeliac disease in the elderly: case reportEvidence of Transient IgA Anti-Endomysial Antibody Positivity in a Patient with Graves’ DiseaseThe Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single CenterThe Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
P50
Q26798289-AEED600B-E835-4F3F-822D-5E9C2FDB5FFEQ30421450-A68FFF2F-ED30-434D-8311-C52E3E3A1518Q33780124-6F041EC3-6B3C-4B25-B47C-C266ACEF0A0EQ34380767-E428944F-2661-4FC9-999D-C41A7DFFE436Q36721763-D85AEE49-C192-435E-86B4-7CACFC2F676AQ37350201-BDFE60D6-42F2-4B3B-8B6A-E3D897C62DB2Q38106951-55CB6ED8-B112-4A96-922D-0459C3624403Q38257383-7A845903-965C-48CD-9F10-1A23B1DC97DDQ38332035-7944C6AB-9935-4990-AA48-9CB736814D72Q39575398-EC837D3F-4C5C-4F96-AE44-ED0A96F8ED5FQ39878775-2677A1D7-26D3-4DC1-8FF3-C2DF141E400CQ40376834-F38570FA-6E45-4E41-AE15-C829296330BDQ41715697-A1FA1A5F-51A6-46EA-8CFB-428257A4DF4EQ42206491-F2889843-F1F4-415E-86D3-452848495E25Q43032258-F8AFF148-BC76-487D-ABA5-45CD9B63BC76Q43042518-E9E4B780-B52A-4F2D-8B85-44BCFCBB402CQ43141036-49391D84-EA45-4E8E-945A-A7C0C044D66EQ43587697-01167C24-DCFA-48FB-8E77-9DB09A6CE709Q44302280-5181E8D9-B40A-40A1-94BE-13D700213BB9Q44622043-E5BD4A42-CDBE-445B-BFE5-B23B78EF6D80Q45358913-F8C896B5-E8D5-4837-B456-789AE5C123A6Q46105505-2B7B41BD-A0C2-4718-ACA3-C606EDA825DCQ46694652-CD658DAB-3C58-4852-B131-F279792CFE62Q51793952-759D1062-276C-4051-9103-BD393C357058Q53360037-8391652A-B33F-413F-80E2-0C76F4A7E5C4Q53497971-6747C257-AD8F-41B0-8096-5762B64E76CCQ54387297-03C895E8-6619-49CA-BFF9-487D7C0919C0Q59149884-FD618AD5-790C-4537-851C-57C8C10B2E82Q62021798-C60EA5AB-7E79-4253-9388-B5DD45BD1F7EQ62021802-2D76A0E2-78BC-4E07-9EFC-86470AB8C9F9Q62021808-75F9C828-1E64-4B32-A9D5-8F1684C4B789Q62021809-782ADDB0-899D-480E-A68E-322C0CA7CA5CQ62021812-0CB2A151-4FFD-4D1A-9C45-51345A7DF595Q62021822-34436DCF-6118-4972-ADFD-6338264C6212Q62021824-99373FAA-2D26-4990-8F42-EAAE2271982BQ62021827-75A002A9-A569-405C-B32D-3D41D0D16E24Q62021829-2B7A8402-A122-472B-B5CB-710C1634F190Q62021835-806C957A-B9D9-425E-9D34-74E0030FED5CQ90414520-EEE732BD-EE4B-4A4D-A353-1AA3DCE74849Q95265330-7A07FB02-0E5C-4F13-B62E-26E62C2A3E56
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lydia Giannitrapani
@ast
Lydia Giannitrapani
@en
Lydia Giannitrapani
@es
Lydia Giannitrapani
@nl
Lydia Giannitrapani
@sl
type
label
Lydia Giannitrapani
@ast
Lydia Giannitrapani
@en
Lydia Giannitrapani
@es
Lydia Giannitrapani
@nl
Lydia Giannitrapani
@sl
prefLabel
Lydia Giannitrapani
@ast
Lydia Giannitrapani
@en
Lydia Giannitrapani
@es
Lydia Giannitrapani
@nl
Lydia Giannitrapani
@sl
P106
P1153
6603524141
P21
P31
P496
0000-0003-2845-5296